apparent mineralocorticoid excess syndrome

From Aaushi
Jump to navigation Jump to search

Etiology

Pathology

Genetics

Clinical manifestations

Laboratory

Complications

Differential diagnosis

Management

More general terms

References

  1. 1.0 1.1 Medical Knowledge Self Assessment Program (MKSAP) 15, 17. American College of Physicians, Philadelphia 2009, 2015,
    Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025
  2. Carvajal CA, Tapia-Castillo A, Vecchiola A, et al. Classic and nonclassic apparent mineralocorticoid excess syndrome. J Clin Endocrinol Metab. 2020;105. PMID: https://pubmed.ncbi.nlm.nih.gov/31909799
  3. Zennaro MC, Rickard AJ, Boulkroun S. Genetics of mineralocorticoid excess: an update for clinicians. Eur J Endocrinol. 2013 Jun 1;169(1):R15-25. Review. PMID: https://pubmed.ncbi.nlm.nih.gov/23610123 Free Article
  4. Melcescu E, Phillips J, Moll G, Subauste JS, Koch CA. 11Beta-hydroxylase deficiency and other syndromes of mineralocorticoid excess as a rare cause of endocrine hypertension. Horm Metab Res. 2012 Nov;44(12):867-78. Review. PMID: https://pubmed.ncbi.nlm.nih.gov/22932914

Database